Portfolio Manager Carl Brown discusses valuations in the biotech industry. What does he look for in an area that led the market before correcting in 2015's third quarter?
Related Commentary:
Portfolio Manager Carl Brown discusses valuations in the biotech industry. What does he look for in an area that led the market before correcting in 2015's third quarter?
Related Commentary: